{"id":"nidroxyzone","rwe":[{"pmid":"14340744","year":"1965","title":"THE EFFECT OF NIDROXYZONE AND NIHYDRAZONE ON LAYING HENS.","finding":"","journal":"Poultry science","studyType":"Clinical Study"},{"pmid":"13696277","year":"1961","title":"Effects of nidroxyzone on reproductive organs of mice.","finding":"","journal":"Endocrinology","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"furaxolon","offLabel":[],"synonyms":["nidroxyzone","furadroxyl","furaxolon","nidroxyzon","nitrofuroxizonum"],"timeline":[],"approvals":[],"brandName":"Furaxolon","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine Furaxolon as a key that fits into a specific lock in the body. When it binds to that lock, it can turn on or off certain cellular processes, which can help to treat a particular disease or condition. This is a simplified explanation of how Furaxolon works at a molecular level.","oneSentence":"Furaxolon works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"Furaxolon is a small molecule that likely interacts with its target through non-covalent binding, potentially altering the conformation or activity of the target protein, which in turn modulates downstream signaling pathways to produce its therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3794","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NIDROXYZONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:39:26.726061","biosimilars":[],"competitors":[],"genericName":"nidroxyzone","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"YN9DMN3CVQ","CHEBI":"CHEBI:134984","INN_ID":"693","UMLSCUI":"C0068734","ChEMBL_ID":"CHEMBL92444","PUBCHEM_CID":"9570072","MESH_SUPPLEMENTAL_RECORD_UI":"C008616"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1965 Mar","pmid":"14340744","title":"THE EFFECT OF NIDROXYZONE AND NIHYDRAZONE ON LAYING HENS.","journal":"Poultry science"},{"date":"1961 Aug","pmid":"13696277","title":"Effects of nidroxyzone on reproductive organs of mice.","journal":"Endocrinology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Furaxolon, also known as NIDROXYZONE, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. The approved indications for Furaxolon are also unknown. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. Further research is needed to fully understand its mechanism of action and safety profile.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}